From the Food and Drug Administration.
Nightingale
S L
SL
D000818:Animals; D000975:Antioxidants / Q000009:adverse effects*; D002839:Chromans / Q000009:adverse effects*; D003195:Computer Communication Networks; D004348:Drug Labeling; D016903:Drug Monitoring; D005260:Female; D005514:Food Irradiation; D006801:Humans; D007255:Information Services; D008460:Meat / Q000382:microbiology; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D011247:Pregnancy; D012106:Research / Q000592:standards*; D013726:Terbutaline / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*; D045162:Thiazolidinediones; D015149:Tocolytic Agents / Q000009:adverse effects*; D000077288:Troglitazone; D014481:United States; D014486:United States Food and Drug Administration
D000975:Antioxidants; D002839:Chromans; D013844:Thiazoles; D045162:Thiazolidinediones; D015149:Tocolytic Agents; D000077288:Troglitazone; D013726:Terbutaline